+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
From
From
From
From
Ischemic Stroke Market and Forecast Analysis 2024 - Product Thumbnail Image

Ischemic Stroke Market and Forecast Analysis 2024

  • Drug Pipelines
  • January 2019
  • 163 Pages
  • Global
From
From
Heparin Market 2024-2028 - Product Thumbnail Image

Heparin Market 2024-2028

  • Report
  • November 2023
  • 165 Pages
  • Global
From
Stroke Therapeutics Market 2021-2025 - Product Thumbnail Image

Stroke Therapeutics Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
Heart Failure Drugs Market 2021-2025 - Product Thumbnail Image

Heart Failure Drugs Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
From
From
From
Coronary Stents-Pipeline Insight and Competitive Landscape, 2022 - Product Thumbnail Image

Coronary Stents-Pipeline Insight and Competitive Landscape, 2022

  • Drug Pipelines
  • July 2022
  • 60 Pages
  • Global
From
From
From
From
Cerebral vein thrombosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cerebral vein thrombosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Deep Vein Thrombosis (DVT) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Deep Vein Thrombosis (DVT) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more